Advertisement

Heart Failure Reviews

, Volume 23, Issue 6, pp 849–857 | Cite as

Implantable devices to monitor patients with heart failure

  • Nikolaos Karamichalakis
  • John Parissis
  • George Bakosis
  • Vasiliki Bistola
  • Ignatios Ikonomidis
  • Antonios Sideris
  • Gerasimos Filippatos
Article
  • 229 Downloads

Abstract

Reducing heart failure hospitalizations represents a major challenge for modern clinicians. Early detection of congestion plays a key role in disease management strategy. Apart from traditional methods (patient reporting symptoms, body weight monitoring), novel home-care strategies allow guided adjustments in medical therapy through telemonitoring embedded in cardiac electronic implantable devices or through stand-alone diagnostic devices for hemodynamic monitoring. Wireless pulmonary artery pressure monitoring seems to reduce re-admission risk and is currently approved for this purpose in patients with heart failure. Multiparameter monitoring is also appealing and could be a valuable tool in managing these patients. However, invasive techniques face several safety concerns and cost-effectiveness issues. Therefore, quest for future research and emerging technologies is necessary.

Keywords

Telemonitoring Heart failure Implantable hemodynamic monitoring devices Cardiac resynchronization therapy Implantable cardioverter defibrillator Review 

Notes

Compliance with ethical standards

Conflict of interest

Authors Nikolaos Karamichalakis, George Bakosis, Vasiliki Bistola, Ignatios Ikonomidis, and Antonios Sideris declare no conflict of interest. Author John Parissis has received horonaria for lectures from Servier, Novartis, and Roche diagnostics. Author Gerasimos Filippatos is committee member in trials sponsored by Novartis, Medtronic, Bayer, and Servier.

References

  1. 1.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 131(4):e29–e322.  https://doi.org/10.1161/cir.0000000000000152 CrossRefGoogle Scholar
  2. 2.
    Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975.  https://doi.org/10.1002/ejhf.592 CrossRefGoogle Scholar
  3. 3.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C (2016) 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134(13):e282–e293.  https://doi.org/10.1161/cir.0000000000000435 CrossRefPubMedGoogle Scholar
  4. 4.
    Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34(29):2281–2329.  https://doi.org/10.1093/eurheartj/eht150 CrossRefPubMedGoogle Scholar
  5. 5.
    Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T, Svendsen JH, Vos MA, Anker SD, Coats AJ, Haverkamp W, Manolis AS, Chung MK, Sanders P, Pieske B (2015) European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Eur J Heart Fail 17(9):848–874.  https://doi.org/10.1002/ejhf.338 CrossRefPubMedGoogle Scholar
  6. 6.
    Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The EuroHeart failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442–463CrossRefGoogle Scholar
  7. 7.
    Stewart S (2005) Financial aspects of heart failure programs of care. Eur J Heart Fail 7(3):423–428.  https://doi.org/10.1016/j.ejheart.2005.01.001 CrossRefPubMedGoogle Scholar
  8. 8.
    Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154(2):260–266.  https://doi.org/10.1016/j.ahj.2007.01.041 CrossRefPubMedGoogle Scholar
  9. 9.
    Adamson PB (2009) Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep 6(4):287–292CrossRefGoogle Scholar
  10. 10.
    Lewin J, Ledwidge M, O'Loughlin C, McNally C, McDonald K (2005) Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail 7(6):953–957.  https://doi.org/10.1016/j.ejheart.2005.06.003 CrossRefPubMedGoogle Scholar
  11. 11.
    Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA (2011) Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 17(2):51–55.  https://doi.org/10.1111/j.1751-7133.2011.00220.x CrossRefPubMedGoogle Scholar
  12. 12.
    Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC (2008) Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118(14):1433–1441.  https://doi.org/10.1161/circulationaha.108.783910 CrossRefPubMedGoogle Scholar
  13. 13.
    Cleland JG, Antony R (2011) It makes SENSE to take a safer road. Eur Heart J 32(18):2225–2227.  https://doi.org/10.1093/eurheartj/ehr120 CrossRefPubMedGoogle Scholar
  14. 14.
    Ferrante D, Varini S, Macchia A, Soifer S, Badra R, Nul D, Grancelli H, Doval H (2010) Long-term results after a telephone intervention in chronic heart failure: DIAL (randomized trial of phone intervention in chronic heart failure) follow-up. J Am Coll Cardiol 56(5):372–378.  https://doi.org/10.1016/j.jacc.2010.03.049 CrossRefPubMedGoogle Scholar
  15. 15.
    Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ (2008) Effect of moderate or intensive disease management program on outcome in patients with heart failure: coordinating study evaluating outcomes of advising and counseling in heart failure (COACH). Arch Intern Med 168(3):316–324.  https://doi.org/10.1001/archinternmed.2007.83 CrossRefGoogle Scholar
  16. 16.
    Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH (2005) Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45(10):1654–1664.  https://doi.org/10.1016/j.jacc.2005.01.050 CrossRefPubMedGoogle Scholar
  17. 17.
    Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG (2011) Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane review. Eur J Heart Fail 13(9):1028–1040.  https://doi.org/10.1093/eurjhf/hfr039 CrossRefPubMedGoogle Scholar
  18. 18.
    Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM (2010) Telemonitoring in patients with heart failure. N Engl J Med 363(24):2301–2309.  https://doi.org/10.1056/NEJMoa1010029 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sarrafzadeh M, Tong K, Fonarow GC (2016) Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition -- heart failure (BEAT-HF) randomized clinical trial. JAMA Intern Med 176(3):310–318.  https://doi.org/10.1001/jamainternmed.2015.7712 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Abraham WT, Stough WG, Pina IL, Linde C, Borer JS, De Ferrari GM, Mehran R, Stein KM, Vincent A, Yadav JS, Anker SD, Zannad F (2014) Trials of implantable monitoring devices in heart failure: which design is optimal? Nat Rev Cardiol 11(10):576–585.  https://doi.org/10.1038/nrcardio.2014.114 CrossRefPubMedGoogle Scholar
  21. 21.
    Reynolds DW, Bartelt N, Taepke R, Bennett TD (1995) Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 25(5):1176–1182CrossRefGoogle Scholar
  22. 22.
    Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T (2003) Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41(4):565–571CrossRefGoogle Scholar
  23. 23.
    Zile MR, Bourge RC, Bennett TD, Stevenson LW, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Kueffer FJ (2008) Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial. J Card Fail 14(10):816–823.  https://doi.org/10.1016/j.cardfail.2008.07.235 CrossRefPubMedGoogle Scholar
  24. 24.
    Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW (2008) Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51(11):1073–1079.  https://doi.org/10.1016/j.jacc.2007.10.061 CrossRefPubMedGoogle Scholar
  25. 25.
    Abraham WT, Perl L (2017) Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol 70(3):389–398.  https://doi.org/10.1016/j.jacc.2017.05.052 CrossRefPubMedGoogle Scholar
  26. 26.
    Stevenson LW, Zile M, Bennett TD, Kueffer FJ, Jessup ML, Adamson P, Abraham WT, Manda V, Bourge RC (2010) Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail 3(5):580–587.  https://doi.org/10.1161/circheartfailure.109.923300 CrossRefPubMedGoogle Scholar
  27. 27.
    Mooney DM, Fung E, Doshi RN, Shavelle DM (2015) Evolution from electrophysiologic to hemodynamic monitoring: the story of left atrial and pulmonary artery pressure monitors. Front Physiol 6:271.  https://doi.org/10.3389/fphys.2015.00271 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Abraham WT, Adamson PB, Hasan A, Bourge RC, Pamboukian SV, Aaron MF, Raval NY (2011) Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J 161(3):558–566.  https://doi.org/10.1016/j.ahj.2010.10.041 CrossRefPubMedGoogle Scholar
  29. 29.
    Adamson PB, Abraham WT, Aaron M, Aranda JM Jr, Bourge RC, Smith A, Stevenson LW, Bauman JG, Yadav JS (2011) CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail 17(1):3–10.  https://doi.org/10.1016/j.cardfail.2010.08.002 CrossRefPubMedGoogle Scholar
  30. 30.
    Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377(9766):658–666.  https://doi.org/10.1016/s0140-6736(11)60101-3 CrossRefPubMedGoogle Scholar
  31. 31.
    Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, Henderson J, Cowart P, Stevenson LW (2014) Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 7(6):935–944.  https://doi.org/10.1161/circheartfailure.113.001229 CrossRefPubMedGoogle Scholar
  32. 32.
    Heywood JT, Jermyn R, Shavelle D, Abraham WT, Bhimaraj A, Bhatt K, Sheikh F, Eichorn E, Lamba S, Bharmi R, Agarwal R, Kumar C, Stevenson LW (2017) Impact of practice-based management of pulmonary artery pressures in 2000 patients implanted with the CardioMEMS sensor. Circulation 135(16):1509–1517.  https://doi.org/10.1161/circulationaha.116.026184 CrossRefPubMedGoogle Scholar
  33. 33.
    Desai AS, Bhimaraj A, Bharmi R, Jermyn R, Bhatt K, Shavelle D, Redfield MM, Hull R, Pelzel J, Davis K, Dalal N, Adamson PB, Heywood JT (2017) Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “real-world” clinical practice. J Am Coll Cardiol 69(19):2357–2365.  https://doi.org/10.1016/j.jacc.2017.03.009 CrossRefPubMedGoogle Scholar
  34. 34.
    Vaduganathan M, DeFilippis EM, Fonarow GC, Butler J, Mehra MR (2017) Postmarketing adverse events related to the CardioMEMS HF system. JAMA Cardiol 2(11):1277–1279CrossRefGoogle Scholar
  35. 35.
    Schmier JK, Ong KL, Fonarow GC (2017) Cost-effectiveness of remote cardiac monitoring with the CardioMEMS heart failure system. Clin Cardiol 40(7):430–436.  https://doi.org/10.1002/clc.22696 CrossRefPubMedGoogle Scholar
  36. 36.
    Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ (2014) ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 63(21):2304–2322.  https://doi.org/10.1016/j.jacc.2014.03.016 CrossRefPubMedGoogle Scholar
  37. 37.
    Forsberg SA (1971) Relations between pressure in pulmonary artery, left atrium, and left ventricle with special reference to events at end diastole. Br Heart J 33(4):494–499CrossRefGoogle Scholar
  38. 38.
    Hardaway RM 3rd (1982) Pulmonary artery pressure versus pulmonary capillary wedge pressure and central venous pressure in shock. Resuscitation 10(1):47–56CrossRefGoogle Scholar
  39. 39.
    Chaliki HP, Hurrell DG, Nishimura RA, Reinke RA, Appleton CP (2002) Pulmonary venous pressure: relationship to pulmonary artery, pulmonary wedge, and left atrial pressure in normal, lightly sedated dogs. Catheter Cardiovasc Interv 56(3):432–438.  https://doi.org/10.1002/ccd.10203 CrossRefPubMedGoogle Scholar
  40. 40.
    Ritzema J, Melton IC, Richards AM, Crozier IG, Frampton C, Doughty RN, Whiting J, Kar S, Eigler N, Krum H, Abraham WT, Troughton RW (2007) Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation 116(25):2952–2959.  https://doi.org/10.1161/circulationaha.107.702191 CrossRefPubMedGoogle Scholar
  41. 41.
    Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT (2010) Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 121(9):1086–1095.  https://doi.org/10.1161/circulationaha.108.800490 CrossRefPubMedGoogle Scholar
  42. 42.
    Maurer MS, Adamson PB, Costanzo MR, Eigler N, Gilbert J, Gold MR, Klapholz M, Saxon LA, Singh JP, Troughton R, Abraham WT (2015) Rationale and design of the left atrial pressure monitoring to optimize heart failure therapy study (LAPTOP-HF). J Card Fail 21(6):479–488.  https://doi.org/10.1016/j.cardfail.2015.04.012 CrossRefPubMedGoogle Scholar
  43. 43.
    Abraham WT, Adamson PB, Costanzo MR, Eigler N, Gold M, Klapholz M, Maurer M, Saxon L, Singh J, Troughton R (2016) Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial. J Card Fail 22(11):940.  https://doi.org/10.1016/j.cardfail.2016.09.012 CrossRefGoogle Scholar
  44. 44.
    Hubbert L, Baranowski J, Delshad B, Ahn H (2017) Left atrial pressure monitoring with an implantable wireless pressure sensor after implantation of a left ventricular assist device. ASAIO J 63(5):e60–e65.  https://doi.org/10.1097/mat.0000000000000451 CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR (2011) Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 32(18):2266–2273.  https://doi.org/10.1093/eurheartj/ehr050 CrossRefPubMedGoogle Scholar
  46. 46.
    van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124(16):1719–1726.  https://doi.org/10.1161/circulationaha.111.043042 CrossRefPubMedGoogle Scholar
  47. 47.
    Bhimaraj A (2013) Remote monitoring of heart failure patients. Methodist DeBakey Cardiovasc J 9(1):26–31CrossRefGoogle Scholar
  48. 48.
    Adamson PB, Gold MR, Bennett T, Bourge RC, Stevenson LW, Trupp R, Stromberg K, Wilkoff BL, Costanzo MR, Luby A, Aranda JM, Heywood JT, Baldwin HA, Aaron M, Smith A, Zile M (2011) Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the reducing decompensation events utilizing intracardiac pressures in patients with chronic heart failure (REDUCEhf) trial. Congest Heart Fail 17(5):248–254.  https://doi.org/10.1111/j.1751-7133.2011.00247.x CrossRefPubMedGoogle Scholar
  49. 49.
    Brachmann J, Bohm M, Rybak K, Klein G, Butter C, Klemm H, Schomburg R, Siebermair J, Israel C, Sinha AM, Drexler H (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF study (optimization of heart failure management using OptiVol fluid status monitoring and CareLink). Eur J Heart Fail 13(7):796–804.  https://doi.org/10.1093/eurjhf/hfr045 CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Bohm M, Drexler H, Oswald H, Rybak K, Bosch R, Butter C, Klein G, Gerritse B, Monteiro J, Israel C, Bimmel D, Kaab S, Huegl B, Brachmann J (2016) Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J 37(41):3154–3163.  https://doi.org/10.1093/eurheartj/ehw099 CrossRefPubMedGoogle Scholar
  51. 51.
    Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM (2010) Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) study. J Am Coll Cardiol 55(17):1803–1810.  https://doi.org/10.1016/j.jacc.2009.11.089 CrossRefPubMedGoogle Scholar
  52. 52.
    Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M (2012) Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125(24):2985–2992.  https://doi.org/10.1161/circulationaha.111.088971 CrossRefPubMedGoogle Scholar
  53. 53.
    Arya A, Block M, Kautzner J, Lewalter T, Mortel H, Sack S, Schumacher B, Sogaard P, Taborsky M, Husser D, Hindricks G (2008) Influence of home monitoring on the clinical status of heart failure patients: design and rationale of the IN-TIME study. Eur J Heart Fail 10(11):1143–1148.  https://doi.org/10.1016/j.ejheart.2008.08.004 CrossRefPubMedGoogle Scholar
  54. 54.
    Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Sogaard P (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384(9943):583–590.  https://doi.org/10.1016/s0140-6736(14)61176-4 CrossRefPubMedGoogle Scholar
  55. 55.
    Morgan JM, Dimitrov BD, Gill J, Kitt S, Ng GA, McComb JM, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Yao GL, Cowie MR (2014) Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures. Eur J Heart Fail 16(9):1039–1045.  https://doi.org/10.1002/ejhf.149 CrossRefPubMedGoogle Scholar
  56. 56.
    Morgan JM, Kitt S, Gill J, McComb JM, Ng GA, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Harris S, Cowie MR (2017) Remote management of heart failure using implantable electronic devices. Eur Heart J 38(30):2352–2360.  https://doi.org/10.1093/eurheartj/ehx227 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Evangelismos General HospitalAthensGreece
  2. 2.Attikon General University HospitalChaidariGreece
  3. 3.Medical School, University of Cyprus, University House “Anastasios G. Leventis”NicosiaCyprus

Personalised recommendations